Ryman’s turnaround is well under way: Forsyth Barr

Ryman’s turnaround is well under way: Forsyth Barr
Forsyth Barr's Aaron Ibbotson rates Ryman shares as "outperform". (Image: Forsyth Barr)
Jenny Ruth
Forsyth Barr analyst Aaron Ibbotson has taken a deep dive into Ryman Healthcare‘s debt position and its turnaround strategy and concluded it is “changing its stripes more than the market is giving it credit for”.The market has certainly exhibited extreme disillusion with the stock in recent weeks.Ryman shares fell as low as $4.82 after it completed its $902 million capital raising, compared with the rights issue price of $5 per new share and $6.40 before the mid-February announcement.The shares closed at $5.22 on Tuesday.A goo...

More Markets

Global markets rise as EU/US trade deal agreed
Markets

Global markets rise as EU/US trade deal agreed

One trade deal settled, China still to come.

AFP 3:35pm
King Honey calls in the receivers
Markets

King Honey calls in the receivers

Parent company Me Today failed to find a buyer for the mānuka honey business.

Spark begins board refresh, Justine Smyth succession in motion
Markets

Spark begins board refresh, Justine Smyth succession in motion

Gordon MacLeod and Sheridan Broadbent are to step down amid broader succession moves. 

NZX up 0.45% on ‘very quiet’ trading day
Markets Market Close

NZX up 0.45% on ‘very quiet’ trading day

Total value traded fell short of $75 million.